Posted on December 22, 2010 by Sitemaster
The adverse effects of androgen deprivation therapy (ADT) resulting from the use of surgical castration (orchiectomy) or medical castration (luteinizing hormone-releasing hormone [LHRH] agonists) are extensive, including sexual dysfunction, hot flashes, osteoporosis, and many others. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, adverse effects, androgen deprivation, estogen | Leave a comment »
Posted on November 29, 2008 by Sitemaster
We have separately addressed a report on 10-year outcome data following (non-robotic) laparoscopic radical prostatectomy for localized prostate cancer. In today’s other reports we have addressed:
- The potential of annexin A3 as a marker for early diagnosis of prostate cancer
- The ability of PSAV and PSAD to predict risk for prostate cancer in men with one or more negative prostate biopsies
- Estrogens, estrogen receptors, and prostate cancer development and progression
- Differences between clinical and pathological Gleason scores and the impact on outcomes following surgery … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: annexin, estogen, Gleason score, marker, PSA density, PSA velocity, receptor | Leave a comment »
